CoChat

Hypogonadism in male patients with cancer

Open access
Garcia, Jose M., Li, Huiling, Mann, Douglas, Epner, Daniel, Hayes, Teresa G., Marcelli, Marco, Cunningham, Glenn R. · 2006 · Cancer
Cited by 100

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Patients with cancer often develop anorexia, fatigue, and decreased muscle mass. These signs and symptoms are nonspecific, and they frequently occur in other conditions, including hypogonadism. METHODS: The objectives of this study were 1) to measure testosterone levels in patients with cancer and 2) to examine the correlations between testosterone, tumor necrosis factor‐α (TNF‐α), interleukin‐6 (IL‐6), insulin‐like growth factor‐1 (IGF‐1), ghrelin levels, and appetite in patients with cancer patients and in a noncancer control group. This was designed as a cross‐sectional study in the setting of a university‐affiliated Veterans Affairs Medical Center. The study population included 31 male patients with cancer and 25 gender‐matched noncancer controls of similar age. The variables total testosterone (TT), calculated free testosterone (cFT), calculated bioavailable testosterone (cBT), sex hormone‐binding globulin (SHBG), luteinizing hormone (LH), TNF‐α, IL‐6, IGF‐1, and active ghrelin were measured in fasting morning plasma samples. Appetite was measured according to a visual analog scale. The main outcome measures were cFT and cBT. RESULTS: Cancer patients had mean TT levels similar to levels in the noncancer control group but significantly lower levels of cFT, cBT, IGF‐1, and appetite. SHBG, LH, TNF‐α, IL‐6, and ghrelin levels were increased in patients with cancer compared with the control group. cFT and cBT levels were correlated inversely with IL‐6 and ghrelin levels and were correlated directly with IGF‐1 levels and appetite. CONCLUSIONS: Patients with cancer had lower levels of biologically active testosterone. TT was not adequate for the evaluation of hypogonadism, because SHBG levels were increased. A reliable measurement of FT and/or BT should be used. LH was elevated in the patients with cancer, indicating that low FT levels were caused by primary testicular dysfunction. The authors postulated that high IL‐6 or ghrelin levels inhibit testosterone synthesis, although a secondary effect at the hypothalamic‐pituitary levels cannot be excluded. Cancer 2006. © 2006 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.21889

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

Metadata

Authors
Garcia, J. M., Li, H., Mann, D., Epner, D., Hayes, T. G., Marcelli, M., & Cunningham, G. R.
Venue
Cancer
Publisher
Wiley
Published
2006-05-10
Volume
106
Issue
12
Pages
2583-2591
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2047522222
Cited by
100
References
16
FWCI
2.42
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.